104 related articles for article (PubMed ID: 21389298)
1. Upregulation of D2-class signaling in dopamine-denervated striatum is in part mediated by D3 receptors acting on Ca V 2.1 channels via PIP2 depletion.
Prieto GA; Perez-Burgos A; Palomero-Rivero M; Galarraga E; Drucker-Colin R; Bargas J
J Neurophysiol; 2011 May; 105(5):2260-74. PubMed ID: 21389298
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D(2)-class receptor supersensitivity as reflected in Ca2+ current modulation in neostriatal neurons.
Prieto GA; Perez-Burgos A; Fiordelisio T; Salgado H; Galarraga E; Drucker-Colin R; Bargas J
Neuroscience; 2009 Dec; 164(2):345-50. PubMed ID: 19699276
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
Calabresi P; Mercuri NB; Sancesario G; Bernardi G
Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
[TBL] [Abstract][Full Text] [Related]
4. D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons through inhibition of Cav2.2 channels.
Ramanathan S; Tkatch T; Atherton JF; Wilson CJ; Bevan MD
J Neurophysiol; 2008 Feb; 99(2):442-59. PubMed ID: 18094105
[TBL] [Abstract][Full Text] [Related]
5. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32.
Flores-Hernández J; Cepeda C; Hernández-Echeagaray E; Calvert CR; Jokel ES; Fienberg AA; Greengard P; Levine MS
J Neurophysiol; 2002 Dec; 88(6):3010-20. PubMed ID: 12466426
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic M(1) modulation of N and L types of calcium channels is mediated by protein kinase C in neostriatal neurons.
Perez-Burgos A; Perez-Rosello T; Salgado H; Flores-Barrera E; Prieto GA; Figueroa A; Galarraga E; Bargas J
Neuroscience; 2008 Sep; 155(4):1079-97. PubMed ID: 18644425
[TBL] [Abstract][Full Text] [Related]
7. Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease.
Tanganelli S; Sandager Nielsen K; Ferraro L; Antonelli T; Kehr J; Franco R; Ferré S; Agnati LF; Fuxe K; Scheel-Krüger J
Parkinsonism Relat Disord; 2004 Jul; 10(5):273-80. PubMed ID: 15196505
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of 5-HT(2) receptors in prefrontal pyramidal neurons inhibits Ca(v)1.2 L type Ca(2+) currents via a PLCbeta/IP3/calcineurin signaling cascade.
Day M; Olson PA; Platzer J; Striessnig J; Surmeier DJ
J Neurophysiol; 2002 May; 87(5):2490-504. PubMed ID: 11976386
[TBL] [Abstract][Full Text] [Related]
9. Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity.
Harrison LM; LaHoste GJ
Neuroscience; 2006; 137(2):483-92. PubMed ID: 16352400
[TBL] [Abstract][Full Text] [Related]
10. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
11. Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids.
André VM; Cepeda C; Cummings DM; Jocoy EL; Fisher YE; William Yang X; Levine MS
Eur J Neurosci; 2010 Jan; 31(1):14-28. PubMed ID: 20092552
[TBL] [Abstract][Full Text] [Related]
12. A reconfiguration of CaV2 Ca2+ channel current and its dopaminergic D2 modulation in developing neostriatal neurons.
Salgado H; Tecuapetla F; Perez-Rosello T; Perez-Burgos A; Perez-Garci E; Galarraga E; Bargas J
J Neurophysiol; 2005 Dec; 94(6):3771-87. PubMed ID: 16120665
[TBL] [Abstract][Full Text] [Related]
13. Long-term changes in morphology, D2R expression and targets of regenerated dopaminergic terminals in the striatum after a partial lesion in the substantia nigra in the rat.
Zeng X; Shen H; Zhao J; Cai Q; Wang C; Xu Q
Brain Res; 2012 Apr; 1450():166-73. PubMed ID: 22424788
[TBL] [Abstract][Full Text] [Related]
14. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
[TBL] [Abstract][Full Text] [Related]
15. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
Cepeda C; André VM; Yamazaki I; Wu N; Kleiman-Weiner M; Levine MS
Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319
[TBL] [Abstract][Full Text] [Related]
16. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
Lavoute C; Weiss M; Rostain JC
Brain Res; 2007 Oct; 1176():37-44. PubMed ID: 17900538
[TBL] [Abstract][Full Text] [Related]
17. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
Strömberg I; Kehr J; Andbjer B; Fuxe K
Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
[TBL] [Abstract][Full Text] [Related]
18. Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatum.
Cai G; Wang HY; Friedman E
J Pharmacol Exp Ther; 2002 Sep; 302(3):1105-12. PubMed ID: 12183669
[TBL] [Abstract][Full Text] [Related]
19. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
Lavoute C; Weiss M; Rostain JC
Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
[TBL] [Abstract][Full Text] [Related]
20. Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism.
Warre R; Thiele S; Talwar S; Kamal M; Johnston TH; Wang S; Lam D; Lo C; Khademullah CS; Perera G; Reyes G; Sun XS; Brotchie JM; Nash JE
Neurobiol Dis; 2011 Mar; 41(3):591-604. PubMed ID: 20971190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
